RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DAL BELLO MG
Collezione AOU Novara

Items : 7

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab. in Clinical and experimental medicine / Clin Exp Med. 2024 Aug 6;24(1):182. doi: 10.1007/s10238-024-01427-8.

2024
AOU San Luigi di Orbassano
AOU Novara

Gil-Bazo I; Baraibar I; Biello F; Rivoltini L; Chiari R; Baglivo S; Metro G; Passiglia F; Barletta G; Ludovini V; Rijavec E; Alama A; Dellepiane C; Dal Bello MG; Zullo L; Tagliamento M; Longo L; Vanni I; Rossi G; Ostano P; Santamaria S; Guana F; Chiorino G; Marconi S; Genova C; Novello S; Grossi F; Coco S;

The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab. in Cancers / Cancers (Basel). 2021 Jun 22;13(13):3117. doi: 10.3390/cancers13133117.

2021
AOU Novara

Bauckneht M; Genova C; Rossi G; Rijavec E; Dal Bello MG; Ferrarazzo G; Tagliamento M; Donegani MI; Biello F; Chiola S; Zullo L; Raffa S; Lanfranchi F; Cittadini G; Marini C; Lopci E; Sambuceti G; Grossi F; Morbelli S;

Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer. in Clinical breast cancer / Clin Breast Cancer. 2021 Jun;21(3):218-230.e6. doi: 10.1016/j.clbc.2020.09.001. Epub 2020 Sep 6.

2021
AOU Novara

Grossi F; Ballestrero A; Longo L; Burrafato G; Carli F; Cavalieri Z; Sini C; Barletta G; Biello F; Rijavec E; Bonfiglio S; Alama A; Salvi S; Dal Bello MG; Genova C; Vanni I; Fontana V; Mora M; Boccardo S; Coco S;

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Sep;22(9):1603-1610. doi: 10.1007/s12094-020-02305-x. Epub 2020 Feb 11.

2020
AOU Novara

Coco S; Spallarossa P; Alama A; Tagliamento M; Biello F; Rossi G; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Carbone F; Grossi F; Bonaventura A; Dallegri F; Genova C; Montecucco F;

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. in Journal of clinical medicine / J Clin Med. 2019 Oct 1;8(10):1566. doi: 10.3390/jcm8101566.

2019
AOU Novara

Genova C; Boccardo S; Mora M; Rijavec E; Biello F; Rossi G; Tagliamento M; Dal Bello MG; Coco S; Alama A; Vanni I; Barletta G; Bianchi R; Maggioni C; Bruzzi P; Grossi F;

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer. in Clinical & experimental metastasis / Clin Exp Metastasis. 2019 Oct;36(5):449-456. doi: 10.1007/s10585-019-09984-z. Epub 2019 Aug 2.

2019
AOU Novara

Genova C; Dallegri F; Coco S; Spallarossa P; Biello F; Rossi G; Alama A; Tagliamento M; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Bonaventura A; Grossi F; Carbone F; Montecucco F;

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul

2019
AOU Novara

Dallegri F; Coco S; Spallarossa P; Alama A; Tagliamento M; Biello F; Rossi G; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Carbone F; Grossi F; Bonaventura A; Genova C; Montecucco F;